Neuropsichyatric Manifestations of Systemic Lupus Erythematosus: Diagnosis and Treatment Approach

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110-21.10.1056/NEJMra110035922129255Search in Google Scholar

2. Zirkzee EJ, Steup-Beekman GM, van der Mast RC, Bollen EL, van der Wee NJ, Baptist E, et al. Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy. J Rheumatol. 2012;39(11):2118-26.10.3899/jrheum.12054522984275Search in Google Scholar

3. Cesar Magro-Checa, Elisabeth J. Zirkzee, Tom W. Huizinga, Gerda M, Steup-Beekman. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs 2016; 76:459-483 DOI 10.1007/s40265-015-0534-3.10.1007/s40265-015-0534-3479145226809245Search in Google Scholar

4. Tomic-Lucic A, Petrovic R, Radak-Perovic M, et al. Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol 2013; 32: 1053-58.10.1007/s10067-013-2238-y23515605Search in Google Scholar

5. Tomić Lučić A, Petrović R. Sistemski eritemski lupuskasni početak, tok i ishod. Acta Rheumatologica Belgradensia 2011; 41(Supp 1): 89.Search in Google Scholar

6. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1-11.10.1016/j.semarthrit.2010.08.00120965549Search in Google Scholar

7. Kampylafka EI, Alexopoulos H, Kosmidis ML, Panagiotakos DB, Vlachoyiannopoulos PG, Dalakas MC, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. Plos One. 2013;8(2):e55843.10.1371/journal.pone.0055843357056023424638Search in Google Scholar

8. Raquel Faria, Joao Goncalves and Rita Dias. Neuropsychiatric Systemic Lupus Erythematosus Involvement: Towards a Tailored Approach to Our Patients? Rambam Maimonides Med J. 2017; 8(1):e001 doi: 10.5041/RMMJ.10276.Search in Google Scholar

9. Zirkzee EJ, Huizinga TW, Bollen EL, van Buchem MA, Middelkoop HA, van der Wee NJ, et al. Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2014;23(1):31-8.10.1177/096120331351254024243776Search in Google Scholar

10. Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, et al. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum. 2012;42(2):179-85.10.1016/j.semarthrit.2012.03.01122595642Search in Google Scholar

11. Govoni M, Bortoluzzi A, Padovan M, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 2016;74: 41-7.10.1016/j.jaut.2016.06.01327427403Search in Google Scholar

12. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies in systemic lupus erythematosus. Isr Med Assoc J 2015;17:171-8.Search in Google Scholar

13. Gerosa M, Poletti B, Pregnolato F, et al. Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus. Front Immunol 2016;7:5.10.3389/fimmu.2016.00005Search in Google Scholar

14. Noureldine MH, Harifi G, Berjawi A, et al. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? Lupus 2016;25: pii: 0961203316651747.10.26226/morressier.56e174d0d462b8028d88a396Search in Google Scholar

15. Anisur Rahman.Conventional tratments in systemic lupus erythematosus. In: Gordon C, Isenberg D Systemic Lupus Erythematosus.Oxford University press, Oxford; 2016: 79-88.10.1093/med/9780198739180.003.0006Search in Google Scholar

16. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419-23.10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-XSearch in Google Scholar

17. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56: 265-73.10.1002/art.22305Search in Google Scholar

18. Fanouriakis A, Pamfil C, Rednic S, Sidiropoulos P, Bertsias G, Boumpas DT. Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard. Clin Exp Rheumatol 2016;34: 910-1.Search in Google Scholar

19. Alessandra Bortoluzzi, Carlo Alberto Scire, Stefano Bombardieri, Luisa Caniatti, Fabrizio Conti, Salvatore De Vita6, Andrea Doria et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 2015;54:891-98 doi:10.1093/rheumatology/keu384.Search in Google Scholar

20. Hanley G, Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014; 10:338-47.10.1038/nrrheum.2014.15Search in Google Scholar

21. Rhodes B and Gordon C. Clinical features of systemic lupus erythematosus. In: Gordon C, Isenberg D Systemic Lupus Erythematosus.Oxford University press, Oxford; 2016, 45-62.10.1093/med/9780198739180.003.0004Search in Google Scholar

22. Sarbu N, Alobeidi F, Toledano P, et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 2015;14:153-9.10.1016/j.autrev.2014.11.001Search in Google Scholar

23. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010;69:2074-82.10.1136/ard.2010.130476Search in Google Scholar

24. Sarbu N, Bargallo N, Cervera R. Advanced and conventional magnetic resonance imaging in neuropsychiatric lupus. Version 2. F1000Res. 2015 Jun 23 [revised 2015 Jul 28];4:16.10.12688/f1000research.6522.2450578826236469Search in Google Scholar

25. Gal Y, Twig G, Mozes O, Greenberg G, Hoffmann C, Shoenfeld Y. Central nervous system involvement in systemic lupus erythematosus: an imaging challenge. Isr Med Assoc J 2013;15:382-6.Search in Google Scholar

26. C Muangchan, R Van Vollenhoven, S Bernatsky, D Smith, M Hudson, M Inanc et al. Treatment Algorithms in Systemic Lupus Erythematosus . Arthritis Care & Research 2015; 67( 9): 1237-1245.10.1002/acr.2258925777803Search in Google Scholar

27. Gonzalez LA, Pons-Estel GJ, Zhang J, et al. Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort. Lupus 2009;18: 822-30.10.1177/0961203309104392375915019578107Search in Google Scholar

28. Cavaco S, Martins da Silva A, Santos E, et al. Hydroxychloroquine and cognition in systemic lupus erythematosus. Lupus 2014;23.Search in Google Scholar

29. Magro-Checa C, Zirkzee EJ, Huizinga TW, SteupBeekman GM. Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives. Drugs 2016;76:459-83.10.1007/s40265-015-0534-3479145226809245Search in Google Scholar

30. Fanouriakis A, Pamfil C, Sidiropoulos P, et al. Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study. Lupus 2016;25:627-36.10.1177/096120331562282126692040Search in Google Scholar

31. Fernandes Moca Trevisani V, Castro AA, Ferreira Neves Neto J, Atallah AAN. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database Syst Rev 2013;(2):CD002265.10.1002/14651858.CD002265.pub3682322223450535Search in Google Scholar

32. Higashioka K, Yoshida K, Oryoji K, et al. Successful treatment of lupus cerebrovascular disease with mycophenolate mofetil. Intern Med 2015;54:2255-9.10.2169/internalmedicine.54.458226328657Search in Google Scholar

33. Farinha F, Abrol E, Isenberg DA. Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 2016;25:1278-9.10.1177/096120331663163626873650Search in Google Scholar

34. C Pamfil, A Fanouriakis, L Damian, M Rinzis, P Sidiropoulos, G Tsivgoulis et al. EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford) 2015; 54 (7): 1270-1278.10.1093/rheumatology/keu48225638807Search in Google Scholar